DD55956A - - Google Patents

Info

Publication number
DD55956A
DD55956A DD55956DA DD55956A DD 55956 A DD55956 A DD 55956A DD 55956D A DD55956D A DD 55956DA DD 55956 A DD55956 A DD 55956A
Authority
DD
German Democratic Republic
Application number
Publication of DD55956A publication Critical patent/DD55956A/xx

Links

DD55956D DD55956A (en:Method)

Publications (1)

Publication Number Publication Date
DD55956A true DD55956A (en:Method)

Family

ID=251922

Family Applications (1)

Application Number Title Priority Date Filing Date
DD55956D DD55956A (en:Method)

Country Status (1)

Country Link
DD (1) DD55956A (en:Method)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302132A1 (de) * 1987-01-27 1989-02-08 Deutsche Hydrierwerke GmbH Rodleben Verfahren und Vorrichtung zur Herstellung von 5-Methyl-7-diethylamino-s-triazolo(1,5-a)-pyrimidin
WO2002002563A3 (en) * 2000-06-30 2003-01-03 Wyeth Corp Substituted-triazolopyrimidines as anticancer agents
WO2004108136A1 (en) * 2003-06-04 2004-12-16 Vernalis (Cambridge) Limited Triazolo `1 , 5-a!pyrimidines and their use in medicine
WO2005025315A1 (en) * 2003-09-12 2005-03-24 Basf Aktiengesellschaft 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302132A1 (de) * 1987-01-27 1989-02-08 Deutsche Hydrierwerke GmbH Rodleben Verfahren und Vorrichtung zur Herstellung von 5-Methyl-7-diethylamino-s-triazolo(1,5-a)-pyrimidin
WO2002002563A3 (en) * 2000-06-30 2003-01-03 Wyeth Corp Substituted-triazolopyrimidines as anticancer agents
AU2001273062B2 (en) * 2000-06-30 2005-11-24 Wyeth Substituted-triazolopyrimidines as anticancer agents
WO2004108136A1 (en) * 2003-06-04 2004-12-16 Vernalis (Cambridge) Limited Triazolo `1 , 5-a!pyrimidines and their use in medicine
WO2005025315A1 (en) * 2003-09-12 2005-03-24 Basf Aktiengesellschaft 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests
EA010091B1 (ru) * 2003-09-12 2008-06-30 Басф Акциенгезельшафт 6-ГАЛОГЕНО[1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИНЫ ДЛЯ БОРЬБЫ С ВРЕДИТЕЛЯМИ
AU2004271715B2 (en) * 2003-09-12 2010-08-26 Basf Aktiengesellschaft 6-halogeno-(1,2,4)triazolo(1,5-a)pyrimidines for combating animal pests
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases

Similar Documents

Publication Publication Date Title
US20210115055A1 (en) Lrrk2 inhibitors and methods of making and using the same
US5869486A (en) Fused pyrimidines and pyriazines as pharmaceutical compounds
EP1534709B1 (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors
JP2006501260A5 (en:Method)
JP2010065024A (ja) トリアゾロピリミジン誘導体又はその塩を含有する有害生物防除剤
US20070275961A1 (en) Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine
US20080027079A1 (en) Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
DD55956A (en:Method)